Navigation Links
Blood Pressure Drug Helps Those With Mild Heart Failure

SUNDAY, May 22 (HealthDay News) -- New Swedish research suggests that the drug Inspra reduces the threat of major cardiovascular complications among patients who have a mild form of heart failure.

This latest finding builds on earlier work that was published by the New England Journal of Medicine last fall. That study suggested that Inspra (eplerenone), an aldosterone antagonist, helps control cardiovascular complications among patients with a history of serious chronic heart failure.

Since far more people suffer from mild heart failure, this new finding could mean the drug might benefit a far broader group of patients, the researchers added.

The Swedish analysis makes an even stronger case for the use of Inspra in patients with mild heart failure because, in addition to reducing mortality, it also reduces the incidence of the irregular heart beat condition known as atrial fibrillation, study co-author Karl Swedberg, from the University of Gothenburg in Sweden, said in a news release from the European Society of Cardiology.

Atrial fibrillation "is a condition which both increases morbidity and complicates the care of patients with heart failure," he explained.

Swedberg and his colleagues were slated to present the findings Sunday in Gothenburg at the Heart Failure Congress 2011, organized by the Heart Failure Association of the European Society of Cardiology.

The study team noted that Inspra is currently approved for the control of high blood pressure as well as for the treatment of heart attack patients who experience congestive heart failure. It is not yet approved for the treatment of patients who experience mild heart failure. It is available generically in the United States, according to the news release.

Experts estimate that almost 6 million people in the United States suffer from heart failure.

The current finding stems from a re-analysis of a larger study that involved more than 2,700 heart failure patients being cared for at 278 different health centers.

Focusing specifically on those participants who had experienced mild (class 2) heart failure, the authors found that just 2.7 percent of those patients who were placed on a regimen of between 25 milligrams to 50 milligrams daily of Inspra for a little less than two years experienced atrial fibrillation.

This compared with 4.5 percent of those patients who were randomized to receive a sugar pill instead.

Dr. Byron K. Lee, director of the Electrophysiology Laboratories and Clinics within the division of cardiology at the University of California, San Francisco, noted that exactly how Inspra seems to help heart patients is not well understood.

"It is unclear how eplerenone works to lower the risk of abnormal heart rhythms like atrial fibrillation and atrial flutter," he said. "However, there are many potential mechanisms. One possibility is that eplerenone may help maintain potassium levels. Patients with heart failure are often on high-dose diuretics that remove fluid at the expense of removing potassium. Thats why heart failure patients need to watch their potassium level vigilantly."

More information

For more on atrial fibrillation, go to National Library of Medicine.

-- Alan Mozes

SOURCE: Byron K. Lee, M.D., director, Electrophysiology Laboratories and Clinics, division of cardiology, University of California, San Francisco; European Society of Cardiology, news release, May 22, 2011

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Psoriasis, High Blood Pressure May Be Linked
2. Research provides insight into quality of stored blood used for transfusions
3. Unnecessary Blood Tests Plunge After Cost Reminders: Study
4. Findings could lead to a blood test for lung cancer
5. Study reveals origins of a cancer affecting the blood and bone marrow
6. Chronic Tylenol Use May Be Linked to Blood Cancer, Study Suggests
7. Blood test for colon cancer screening beneficial for some seniors, but not for many others
8. Adalimumab levels detected in cord blood and infants exposed in utero
9. Blood Pressure May Hint at Kidney Cancer Outcome
10. Structured Exercise Programs Help Lower Blood Sugar, Study Finds
11. Religion Doesnt Help Lower Blood Pressure, Study Suggests
Post Your Comments:
Related Image:
Blood Pressure Drug Helps Those With Mild Heart Failure
(Date:11/26/2015)... ... 2015 , ... Somu Sivaramakrishnan announced today that he joined ... offers travelers, value and care based Travel Services, including exclusive pricing on a ... cabin upgrades and special amenities such as, shore excursions, discounted fares, travel gifts ...
(Date:11/26/2015)... Aliso Viejo, CA (PRWEB) , ... November 26, ... ... X users a new set of retro-fused, self-animating trailer titles with ProTrailer: Vintage. ... custom style options. These classically-influenced trailer titles work with any font, giving users ...
(Date:11/25/2015)... ... 25, 2015 , ... The holiday season is jam-packed with ... palates of attendees is of the utmost importance. Whether you are cooking at ... these recipes a try this holiday season. , Turkey Croquettes , ...
(Date:11/25/2015)... ... November 26, 2015 , ... Ministers, senior government ... ANDI Pan African Centres of Excellence, and public R&D institutions, civil societies and ... opening of the 5th African Network for Drugs and Diagnostics Innovation, ANDI, Stakeholders ...
(Date:11/25/2015)... , ... November 25, 2015 , ... Dental professionals who ... Cleveland, OH , are invited to attend Dr. Mark Iacobelli’s Advanced Implant Mentoring (AIM) ... in Cleveland, OH. , As the co-founders of Advanced Implant Mentoring (AIM), Dr. ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , 26 november 2015 ... kondigt de geplande investering aan van ten ... de laboratoria en het mondiale hoofdkantoor in ... uitbreiding zal resulteren in extra kantoorruimte en ... aan de groeiende behoeften van de farmaceutische ...
(Date:11/26/2015)... , Nov. 26, 2015 Research and Markets ( ... Pacific Cardiac Pacemaker Market Outlook to 2019 - Rise in ... Demand " report to their offering. ... Boston scientific and others. ... including Medtronic, Biotronik, Boston scientific and ...
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Surface Testing Market: Supplier Shares, Competitive ... offering.  --> ) ... "2016 Future Horizons and Growth Strategies ...
Breaking Medicine Technology: